Drug Name |
Regadenoson |
Drug ID |
BADD_D01921 |
Description |
Regadenoson is an A2A adenosine receptor agonist that causes coronary vasodilation and used for myocardial perfusion imagining. Manufactured by Astellas and FDA approved April 10, 2008. |
Indications and Usage |
Diagnostic agent for radionuclide myocardial perfusion imaging (MPI) |
Marketing Status |
Prescription |
ATC Code |
C01EB21 |
DrugBank ID |
DB06213
|
KEGG ID |
D05711
|
MeSH ID |
C430916
|
PubChem ID |
219024
|
TTD Drug ID |
D0XE1C
|
NDC Product Code |
62756-234; 65129-1331; 76055-0024; 62147-0220; 71288-201; 42973-229; 59285-029; 0469-6501; 69766-103 |
Synonyms |
regadenoson | Lexiscan | CVT 3146 | CVT3146 | CVT-3146 |